Search research articles
Contact Us
Filters
Showing results (1-10 of 22) with videos related to
Page
of 3
Sort By:
Appetite
|
November 22, 2025
Devaluation insensitivity of event related potentials associated with food cues
Thomas D Sambrook, Andy J Wills, Ben Hardwick, et al.
Neuroimage
|
May 15, 2018
Model-free and model-based reward prediction errors in EEG
Thomas D Sambrook, Ben Hardwick, Andy J Wills, et al.
BMC Rheumatology
|
March 20, 2019
A phase II trial protocol of Tocilizumab in anti-TNF refractory patients with JIA-associated uveitis (the APTITUDE trial)
Athimalaipet V Ramanan, Andrew D Dick, Ashley P Jones, et al.
American Journal of Ophthalmology
|
June 16, 2019
Adalimumab in Juvenile Idiopathic Arthritis-Associated Uveitis: 5-Year Follow-up of the Bristol Participants of the SYCAMORE Trial
Sarah Horton, Ashley P Jones, Catherine M Guly, et al.
The Lancet. Rheumatology
|
April 14, 2020
Tocilizumab in patients with anti-TNF refractory juvenile idiopathic arthritis-associated uveitis (APTITUDE): a multicentre, single-arm, phase 2 trial
Athimalaipet V Ramanan, Andrew D Dick, Catherine Guly, et al.
Trials
|
December 19, 2024
Perceived barriers and facilitators of staff recruiting participants to a randomised controlled trial of a community rehabilitation intervention following hip fracture
Kathryn Harvey, Penelope Ralph, Llinos Haf Spencer, et al.
BMJ Open
|
November 28, 2018
Namaste Care in nursing care homes for people with advanced dementia: protocol for a feasibility randomised controlled trial
Katherine Froggatt, Shakil Patel, Guillermo Perez Algorta, et al.
Trials
|
January 11, 2014
A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis (SYCAMORE Trial)
Athimalaipet V Ramanan, Andrew D Dick, Diana Benton, et al.
Pilot and Feasibility Studies
|
December 15, 2016
Assessing the feasibility of injectable growth-promoting therapy in Crohn's disease
Mabrouka A Altowati, Ashley P Jones, Helen Hickey, et al.
The New England Journal of Medicine
|
April 27, 2017
Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis
Athimalaipet V Ramanan, Andrew D Dick, Ashley P Jones, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 22) with videos related to
Sort By:
Page
of 3
Appetite
|
November 22, 2025
Devaluation insensitivity of event related potentials associated with food cues
Thomas D Sambrook, Andy J Wills, Ben Hardwick, et al.
Neuroimage
|
May 15, 2018
Model-free and model-based reward prediction errors in EEG
Thomas D Sambrook, Ben Hardwick, Andy J Wills, et al.
BMC Rheumatology
|
March 20, 2019
A phase II trial protocol of Tocilizumab in anti-TNF refractory patients with JIA-associated uveitis (the APTITUDE trial)
Athimalaipet V Ramanan, Andrew D Dick, Ashley P Jones, et al.
American Journal of Ophthalmology
|
June 16, 2019
Adalimumab in Juvenile Idiopathic Arthritis-Associated Uveitis: 5-Year Follow-up of the Bristol Participants of the SYCAMORE Trial
Sarah Horton, Ashley P Jones, Catherine M Guly, et al.
The Lancet. Rheumatology
|
April 14, 2020
Tocilizumab in patients with anti-TNF refractory juvenile idiopathic arthritis-associated uveitis (APTITUDE): a multicentre, single-arm, phase 2 trial
Athimalaipet V Ramanan, Andrew D Dick, Catherine Guly, et al.
Trials
|
December 19, 2024
Perceived barriers and facilitators of staff recruiting participants to a randomised controlled trial of a community rehabilitation intervention following hip fracture
Kathryn Harvey, Penelope Ralph, Llinos Haf Spencer, et al.
BMJ Open
|
November 28, 2018
Namaste Care in nursing care homes for people with advanced dementia: protocol for a feasibility randomised controlled trial
Katherine Froggatt, Shakil Patel, Guillermo Perez Algorta, et al.
Trials
|
January 11, 2014
A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis (SYCAMORE Trial)
Athimalaipet V Ramanan, Andrew D Dick, Diana Benton, et al.
Pilot and Feasibility Studies
|
December 15, 2016
Assessing the feasibility of injectable growth-promoting therapy in Crohn's disease
Mabrouka A Altowati, Ashley P Jones, Helen Hickey, et al.
The New England Journal of Medicine
|
April 27, 2017
Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis
Athimalaipet V Ramanan, Andrew D Dick, Ashley P Jones, et al.
Page
of 3